Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oramed Pharmaceuticals Inc. - Common Stock (NQ:ORMP)

2.820 -0.090 (-3.09%)
Streaming Delayed Price Updated: 11:57 AM EST, Dec 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oramed Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
Investment comes at a pivotal moment for Alpha Tau, which is experiencing remarkable growth on multiple fronts, with four active U.S. trial approvals, expansion into multiple internal organ... 
From Alpha Tau Medical Ltd.
Via GlobeNewswire
News headline image
Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock ↗
 
Via Benzinga
News headline image
Unusual volume stocks in Wednesday's session ↗
On Wednesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
News headline image
What's going on in today's session ↗
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024 ↗
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
3 Micro-Cap Moonshots for Fearless Investors ↗
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q1 2024 ↗
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023 ↗
ORMP stock results show that Oramed Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Top 4 Health Care Stocks That May Crash This Quarter ↗
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
News headline image
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations ↗
Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize... 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'. 
Via Benzinga
News headline image
Dow Tumbles 250 Points; CarMax Posts Upbeat Results ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98%... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
News headline image
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 
Via Benzinga
News headline image
Why Oramed Pharmaceuticals Shares Are Trading Higher Today ↗
Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 29 stocks made new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  Tuesday saw 9 companies set new 52-week lows. 
Via Benzinga
News headline image
Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5% ↗
U.S. stocks traded higher toward the end of trading, following the release of inflation data. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗
 
Via Benzinga
News headline image
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity... 
Via Benzinga
News headline image
Wall Street Divided After Key Inflation Reading ↗
Stocks are a mixed bag midday, despite this morning's encouraging consumer price index (CPI). 
Via Talk Markets
News headline image
US Stocks Turn Higher; Dow Jumps 200 Points ↗
U.S. stocks turned higher midway through trading, following the release of inflation data. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 13 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Why Oramed Pharmaceuticals Stock Is Crashing Today ↗
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes. 
Via The Motley Fool
News headline image
AVCT Stock Falls as American Virtual Cloud Technologies Files for Bankruptcy ↗
American Virtual Cloud Technologies (AVCT) stock is taking a beating on Thursday as the company, and two subsidiaries, file for bankruptcy. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.